Page last updated: 2024-08-24

cidofovir anhydrous and Pneumonia

cidofovir anhydrous has been researched along with Pneumonia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hong, DJ; Jhun, BW; Kim, K; Kim, SJ; Park, SB1
Cadranel, J; Gharbi, N; Gille, T; Khalil, A; Le Tinier, JY; Rivière, F; Wislez, M1
Drew, WL; Lalezari, JP1
Bray, M; Huggins, JW; Kefauver, D; Martinez, M; Smee, DF; Thompson, E1
Torres, G1

Reviews

1 review(s) available for cidofovir anhydrous and Pneumonia

ArticleYear
Cytomegalovirus: disease syndromes and treatment.
    Current clinical topics in infectious diseases, 1999, Volume: 19

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Central Nervous System Diseases; Chorioretinitis; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Organophosphonates; Organophosphorus Compounds; Pneumonia; Sexually Transmitted Diseases, Viral

1999

Trials

1 trial(s) available for cidofovir anhydrous and Pneumonia

ArticleYear
Opportunistic infection highlights from the 35th ICAAC.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:10

    Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bacterial Vaccines; CD4 Lymphocyte Count; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Ganciclovir; HIV; Humans; Influenza Vaccines; Mycobacterium avium-intracellulare Infection; Organophosphonates; Organophosphorus Compounds; Pneumonia; Pneumonia, Pneumocystis; Randomized Controlled Trials as Topic; United States; Valacyclovir; Valine; Viremia

1995

Other Studies

3 other study(ies) available for cidofovir anhydrous and Pneumonia

ArticleYear
Outcomes of early administration of cidofovir in non-immunocompromised patients with severe adenovirus pneumonia.
    PloS one, 2015, Volume: 10, Issue:4

    Topics: Adenovirus Infections, Human; Adenoviruses, Human; Cidofovir; Cytosine; Drug-Related Side Effects and Adverse Reactions; Humans; Immunocompromised Host; Medical Records; Organophosphonates; Pneumonia; Respiratory Insufficiency; Retrospective Studies; Treatment Outcome

2015
Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion.
    Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:2

    Topics: Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Infusions, Intravenous; Lung; Middle Aged; Organophosphonates; Papillomavirus Infections; Pneumonia; Respiratory Function Tests; Respiratory Tract Infections; Tomography, X-Ray Computed; Treatment Outcome

2011
Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge.
    The Journal of infectious diseases, 2000, Volume: 181, Issue:1

    Topics: Administration, Intranasal; Aerosols; Animals; Antiviral Agents; Bronchi; Cidofovir; Cowpox; Cytosine; Female; Hemorrhage; Mice; Mice, Inbred BALB C; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Pneumonia; Pulmonary Alveoli; Smallpox; Vaccination

2000